Hyperbilirubinemia

• 

  Subject Areas on Research

  • A Gilbert's syndrome UGT1A1 variant confers susceptibility to tranilast-induced hyperbilirubinemia. 
  • A new syndrome: ascites, hyperbilirubinemia, and hypoalbuminemia after biochemical modulation of fluorouracil with N-phosphonacetyl-L-aspartate (PALA) 
  • Biliary sclerosis after hepatic arterial infusion pump chemotherapy for patients with colorectal cancer liver metastasis: incidence, clinical features, and risk factors. 
  • Cholestatic hepatitis from erythromycin ethylsuccinate. Report of two cases. 
  • Clinical and physiological abnormalities in hepatic function. 
  • Delayed development of sensorineural hearing loss after neonatal hyperbilirubinemia: a case report with brain magnetic resonance imaging. 
  • Eccrine Chromhidrosis in an Adolescent with Sickle Cell Disease. 
  • Floxuridine hepatic arterial infusion associated biliary toxicity is increased by concurrent administration of systemic bevacizumab. 
  • Guideline-based educational intervention to decrease the risk for readmission of newborns with severe hyperbilirubinemia. 
  • Red cell disturbances in the feto-maternal unit. 
  • Rifampin use and safety in hospitalized infants. 
  • The laboratory method as a variable in the interpretation of serum bilirubin fractionation. 
  • The role of oxidative stress, inflammation and acetaminophen exposure from birth to early childhood in the induction of autism.